# REVEAL III: Risk Evaluation and Education for Alzheimer's Disease

> **NCT00462917** · NA · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 290 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **BEHAVIORAL:** Pleiotropic info, in-person disclosure
- **BEHAVIORAL:** AD-only info, in-person disclosure
- **BEHAVIORAL:** Pleiotropic info, phone disclosure
- **BEHAVIORAL:** AD-only info, phone disclosure

## Key facts

- **NCT ID:** NCT00462917
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2018-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00462917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00462917, "REVEAL III: Risk Evaluation and Education for Alzheimer's Disease". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00462917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*